rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2004-8-30
|
pubmed:abstractText |
To retrospectively compare diagnostic value of coregistered fluorine 18 fluorodeoxyglucose positron emission tomographic (PET) and computed tomographic (CT) scans obtained with low-dose nonenhanced CT (PET/CT) with those routinely obtained with contrast material-enhanced CT for staging and restaging of disease in patients with Hodgkin disease or high-grade non-Hodgkin lymphoma.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0033-8419
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright RSNA, 2004
|
pubmed:issnType |
Print
|
pubmed:volume |
232
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
823-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15273335-Adolescent,
pubmed-meshheading:15273335-Adult,
pubmed-meshheading:15273335-Aged,
pubmed-meshheading:15273335-Aged, 80 and over,
pubmed-meshheading:15273335-Contrast Media,
pubmed-meshheading:15273335-Female,
pubmed-meshheading:15273335-Fluorodeoxyglucose F18,
pubmed-meshheading:15273335-Hodgkin Disease,
pubmed-meshheading:15273335-Humans,
pubmed-meshheading:15273335-Lymphoma, Non-Hodgkin,
pubmed-meshheading:15273335-Male,
pubmed-meshheading:15273335-Middle Aged,
pubmed-meshheading:15273335-Neoplasm Staging,
pubmed-meshheading:15273335-Radiopharmaceuticals,
pubmed-meshheading:15273335-Retrospective Studies,
pubmed-meshheading:15273335-Tomography, Emission-Computed,
pubmed-meshheading:15273335-Tomography, X-Ray Computed
|
pubmed:year |
2004
|
pubmed:articleTitle |
Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging--do we need contrast-enhanced CT?
|
pubmed:affiliation |
Department of Nuclear Medicine, University Hospital Zurich, Raemistrasse 100, CH-8091 Zurich, Switzerland.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|